Search Results - "Bugnon, O."

Coherent J/ψ photoproduction in peripheral heavy-ion collisions by Bugnon, O.

“…In 2015, the ALICE Collaboration reported the first measurement of an excess in the yield of at very low transverse momentum ( ) in the forward rapidity region…”
Get full text

HIV‐infected patients' beliefs about their chronic co‐treatments in comparison with their combined antiretroviral therapy by Kamal, S, Bugnon, O, Cavassini, M, Schneider, MP

“…Objectives Thanks to the success of combination antiretroviral therapy (cART), HIV‐infected patients can have almost a normal life expectancy. This has…”
Get full text

Switching Patients With Primary Antibody Deficiencies to Home-Based Subcutaneous Immunoglobulin: Economic Evaluation of An Interprofessional Drug Therapy Management Program by Perraudin, C, Bourdin, A, Berger, J, Bugnon, O

Get full text

Implementation of A Collaborative Pharmacy Practice Model in Nursing Homes of A Swiss Canton: Drug Cost Monitoring Between 2009 and 2012 by Zeukeng, M.J, Niquille, A, Locca, J.F, Perraudin, C, Bugnon, O

Get full text

Switching from a two‐tablet regimen of tenofovir/emtricitabine and efavirenz to a one‐tablet regimen may affect patients’ perceptions and drug management by Rotzinger, A, Locatelli, I, Bugnon, O, Fayet Mello, A, Parienti, J‐J, Cavassini, M, Schneider, M.P

“…Objectives Simplification of antiretroviral therapy enhances a patient's adherence but a new formulation could also lead to new adverse events and changes in…”
Get full text

Coherent $\mathrm{J}/\psi$ photoproduction in peripheral heavy-ion collisions by Bugnon, Ophelie

“…In 2015, the ALICE Collaboration reported the first measurement of an excess in the yield of $\mathrm{J}/\psi$ at very low transverse momentum ($p_t < 0.3…”
Get full text

3619 Oral cancer treatments and adherence: medication event monitoring system assessment for capecitabine by Jeanneret, L. Achtari, Pachinger, C, Montemurro, M, Bauer, J, Hefti, E. Guignard, Bugnon, O, Naoux, R, Luthi, F

Get full text

PND129 - SATISFACTION AND EXPERIENCES OF PATIENTS TAKING FINGOLIMOD AND INVOLVED IN A PHARMACY-BASED PATIENT SUPPORT PROGRAM – SATFINO QUALITATIVE STUDY by Bourdin, A, Dubois, J, Schluep, M, Berger, J, Bugnon, O

Get full text

Agonist-induced desensitization of dopamine D-1 receptors in bovine retina and rat striatum by Ofori, S, Bugnon, O, Schorderet, M

“…We have investigated agonist-induced desensitization of dopamine (DA) D-1 receptor mediated accumulation of adenosine 3':5'-cyclic monophosphate (cAMP) in…”
Get more information

Impact of a Community Pharmacy-Based Information Program on Type 2 Diabetic Patients’ Adherence: Iphodia, a Cluster Randomized Study VS Usual Practice - 12 Month Final Results by Michiels, Y, Bugnon, O, Chicoye, A, Verges, B, Moisan, C, Mechin, H, Allaert, F

“…OBJECTIVES: Despite significant improvements in the follow up of type 2 diabetes patients, Entred's latest results showed an insufficient level-of-control with…”
Get full text

PDB49 - Impact of a Community Pharmacy-Based Information Program on Type 2 Diabetic Patients’ Adherence: Iphodia, a Cluster Randomized Study VS Usual Practice - 12 Month Final Results by Michiels, Y, Bugnon, O, Chicoye, A, Verges, B, Moisan, C, Mechin, H, Allaert, F

Get full text

Impact of a Community Pharmacy-Based Information Program on Type 2 Diabetic Patients’ Adherence to Their Oral Treatment: Iphodia, A Cluster Randomized Study Vs Usual Practice by Michiels, Y, Bugnon, O, Chicoye, A, Verges, B, Moisan, C, Mechin, H, Allaert, F

Get full text

PDB61 - Impact of a Community Pharmacy-Based Information Program on Type 2 Diabetic Patients’ Adherence to Their Oral Treatment: Iphodia, A Cluster Randomized Study Vs Usual Practice by Michiels, Y, Bugnon, O, Chicoye, A, Verges, B, Moisan, C, Mechin, H, Allaert, F

Get full text

PHP121 - Switching Patients With Primary Antibody Deficiencies to Home-Based Subcutaneous Immunoglobulin: Economic Evaluation of An Interprofessional Drug Therapy Management Program by Perraudin, C., Bourdin, A., Berger, J., Bugnon, O.

Get full text

PIH87 - Implementation of A Collaborative Pharmacy Practice Model in Nursing Homes of A Swiss Canton: Drug Cost Monitoring Between 2009 and 2012 by Zeukeng, M.J., Niquille, A., Locca, J.F., Perraudin, C., Bugnon, O.

Get full text

Community pharmacy and general internal medicine are at the same crossroads: some opportunities should be seized by Bugnon, O, Buchmann, M

“…The medicines give some symptoms relief and save lives every day. However, the responsible use of medicines is not definitively attained for the modern health…”
Get more information

Okadaic acid modulates exocytotic and transporter-dependent release of dopamine in bovine retina in vitro by Bugnon, O, Ofori, S, Schorderet, M

“…Bovine retinas were isolated for the study of the modulation of exocytotic and transporter-dependent release of dopamine (DA) in vitro. Endogenous DA was…”
Get full text

PDB113 - PSYCHOMETRIC EVALUATION OF A SELF-REPORTED MEDICATION ADHERENCE MEASURE ADAPTED TO COMMUNITY PHARMACY PRACTICE : THE QUESTIONNAIRE ” TOP SCORE by Michiels, Y., Bugnon, O., Vergez, G., Allaert, F.

Get full text

Medication reviews led by community pharmacists in Switzerland: a qualitative survey to evaluate barriers and facilitators by Niquille, Anne, Lattmann, Chantal, Bugnon, Oliver

“…Objective: 1) To evaluate the participation rate and identify the practical barriers to implementing a community pharmacist-led medication review service in…”
Get full text

Subcutaneous immunoglobulin and support program: what level of interest of patients? by Bourdin, A, Berger, J, Früh, A, Spertini, F, Bugnon, O

“…Two different routes of administration exist for the immunoglobulin therapy: intravenous (Ig IV - monthly administration in medical setting) and subcutaneous…”
Get more information